Skip to main content

Diagnostic options Β· UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 2731–2745 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5734
WFS1 Gene Deafness Autosomal Dominant Type 6 Genetic Test

This test evaluates the WFS1 gene for pathogenic variants associated with autosomal dominant non-syndromic hearing loss, specifically DFNA6.

Whole blood (peripheral), extracted DNA, or FTA card blood spot 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the WFS1 gene", "Copy-number variants (CNVs) within the WFS1 gene"]
Parameters
[]
Preparation
["Pre-test genetic counselling is required", "Provide a three-generation pedigree chart"]
Indications
["Suspected autosomal dominant non-syndromic hearing loss (DFNA6)", "Family history of DFNA6", "Genetic counseling for hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: H90.3
Clinical summary
This test evaluates the WFS1 gene for pathogenic variants associated with autosomal dominant non-syndromic hearing loss, specifically DFNA6.
TEST-5517
WFS1 Gene Wolfram-like Syndrome Autosomal Dominant Genetic Test

This test evaluates the WFS1 gene for mutations associated with autosomal dominant Wolfram-like syndrome.

Peripheral whole blood (EDTA) or FTA card (dried blood spot) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["WFS1 gene mutations", "Copy Number Variants (CNVs) in WFS1"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication without consulting your physician"]
Indications
["Unexplained sensorineural hearing loss", "Optic atrophy", "Early-onset diabetes or diabetes insipidus"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82161-3 ICD-10: E13.8
Clinical summary
This test evaluates the WFS1 gene for mutations associated with autosomal dominant Wolfram-like syndrome.
TEST-5634
WHRN Gene Deafness, Autosomal Recessive Type 31 Genetic Test

This test detects pathogenic variants in the WHRN gene associated with autosomal recessive non-syndromic sensorineural hearing loss (DFNB31) and Usher syndrome type 2D.

Peripheral Whole Blood or FTA Card Finger-Prick 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the WHRN gene", "Copy Number Variations (CNV) in the WHRN gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any medications"]
Indications
["Diagnosis of non-syndromic sensorineural hearing loss", "Diagnosis of Usher syndrome type 2D", "Genetic counseling for families with hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: H90.3
Clinical summary
This test detects pathogenic variants in the WHRN gene associated with autosomal recessive non-syndromic sensorineural hearing loss (DFNB31) and Usher syndrome type 2D.
TEST-1054
Williams Syndrome (Karyotyping + FISH) Test

This test detects the specific microdeletion on chromosome 7 associated with Williams syndrome using both karyotyping and FISH.

Peripheral whole blood (EDTA & heparin tubes) 7–10 days 1,100.00 AED
View
View test specifications and preparation
What it measures
["7q11.23 microdeletion", "Chromosomal abnormalities"]
Parameters
[]
Preparation
[]
Indications
["Suspected Williams syndrome based on clinical features", "Prenatal screening in high-risk families", "Confirmation of diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 45079-5 ICD-10: Q87.8
Clinical summary
This test detects the specific microdeletion on chromosome 7 associated with Williams syndrome using both karyotyping and FISH.
TEST-5357
WISP3 Gene Progressive Pseudorheumatoid Arthropathy of Childhood (PPAC) Genetic Test

This test analyzes the WISP3 gene to detect variants associated with progressive pseudorheumatoid arthropathy of childhood (PPAC). It confirms the genetic basis of this autosomal r...

Peripheral blood (EDTA) or FTA card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["WISP3 gene coding region variants", "Single-nucleotide variants", "Small insertions/deletions"]
Parameters
[]
Preparation
["No fasting required", "No medication adjustment required unless instructed by physician", "Mandatory genetic counselling session before testing"]
Indications
["Suspected progressive pseudorheumatoid arthropathy of childhood (PPAC)", "Family history of PPAC", "Evaluation of early-onset non-inflammatory arthropathy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81267-1 ICD-10: M12.8
Clinical summary
This test analyzes the WISP3 gene to detect variants associated with progressive pseudorheumatoid arthropathy of childhood (PPAC). It confirms the genetic basis of this autosomal recessive skeletal dysplasia.
TEST-4582
WNK1 Gene HSAN2A Genetic Test

This genetic test detects pathogenic variants in the WNK1 gene associated with hereditary sensory and autonomic neuropathy type IIA (HSAN2A).

Whole blood (EDTA), extracted DNA, or FTA card (blood spot) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["WNK1 gene pathogenic variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"]
Parameters
[]
Preparation
["No fasting required", "No special preparation required"]
Indications
["Suspected HSAN2A based on clinical presentation", "Family history suggestive of autosomal recessive inheritance", "Carrier screening for at-risk relatives"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55989-0 ICD-10: G60.8
Clinical summary
This genetic test detects pathogenic variants in the WNK1 gene associated with hereditary sensory and autonomic neuropathy type IIA (HSAN2A).
TEST-3553
WNK4 Gene Pseudohypoaldosteronism Type 2B Genetic Test

This test identifies genetic mutations in the WNK4 gene associated with pseudohypoaldosteronism type 2B (Gordon syndrome).

Peripheral Whole Blood 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["WNK4 gene mutations", "Genetic variants associated with Gordon syndrome"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medications unless advised by your physician"]
Indications
["Suspected pseudohypoaldosteronism type 2B (Gordon syndrome)", "Unexplained hypertension with hyperkalemia", "Family history of Gordon syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: E26.8
Clinical summary
This test identifies genetic mutations in the WNK4 gene associated with pseudohypoaldosteronism type 2B (Gordon syndrome).
TEST-4738
WNT10A Gene Odontoonychodermal Dysplasia Genetic Test

This genetic test analyzes the WNT10A gene to identify mutations associated with odontoonychodermal dysplasia.

Peripheral Blood (Whole Blood) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["WNT10A gene coding region variants", "Pathogenic mutations"]
Parameters
[]
Preparation
[]
Indications
["Clinical features of odontoonychodermal dysplasia", "Positive family history of ectodermal dysplasia syndromes"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82870-0 ICD-10: Q82.4, Z14.8, Z13.228
Clinical summary
This genetic test analyzes the WNT10A gene to identify mutations associated with odontoonychodermal dysplasia.
TEST-2283
WNT10B Gene Split-Hand/Foot Malformation Type 6 Genetic Test

This test analyzes the WNT10B gene for mutations associated with split-hand/foot malformation type 6 (SHFM6). It helps confirm a diagnosis and assess genetic risk.

Whole Blood or DNA FTA Card 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the WNT10B gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of recent transfusions or transplants"]
Indications
["Suspected diagnosis of split-hand/foot malformation type 6 (SHFM6)", "Family history of SHFM6", "Genetic counseling for recurrence risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 51966-0 ICD-10: Q71.6
Clinical summary
This test analyzes the WNT10B gene for mutations associated with split-hand/foot malformation type 6 (SHFM6). It helps confirm a diagnosis and assess genetic risk.
TEST-2251
WNT3 Gene Tetra‑Amelia, Autosomal Recessive Genetic Test

This test evaluates the WNT3 gene for pathogenic variants associated with tetra‑amelia syndrome.

Peripheral whole blood (EDTA) or extracted genomic DNA 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["WNT3 gene sequence", "Pathogenic variants in WNT3"]
Parameters
[]
Preparation
["No fasting required", "Continue all prescribed medications"]
Indications
["Suspected diagnosis of tetra‑amelia syndrome", "Carrier screening for WNT3-related variants", "Prenatal diagnosis", "Family planning counselling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82903-4 ICD-10: Q73.1
Clinical summary
This test evaluates the WNT3 gene for pathogenic variants associated with tetra‑amelia syndrome.
TEST-2327
WNT4 Gene SERKAL Syndrome Genetic Test

This test evaluates the WNT4 gene for variants associated with SERKAL syndrome, characterized by sex reversal, renal agenesis, and adrenal hypoplasia.

Whole Blood (Peripheral) or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic and likely pathogenic variants in the WNT4 gene", "Copy number variations (CNVs) within the WNT4 gene"]
Parameters
[]
Preparation
[]
Indications
["Suspected diagnosis of SERKAL syndrome", "Family history of SERKAL syndrome", "Reproductive risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 79500-5 ICD-10: Q87.8
Clinical summary
This test evaluates the WNT4 gene for variants associated with SERKAL syndrome, characterized by sex reversal, renal agenesis, and adrenal hypoplasia.
TEST-2391
WNT5A Gene (Robinow Syndrome, Autosomal Dominant Type 1) Genetic Test

This test evaluates the WNT5A gene for pathogenic variants associated with autosomal dominant Robinow syndrome.

Whole Blood (EDTA) – 5 mL 3–4 Weeks (expedited options available) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the WNT5A gene coding region", "Canonical splice sites"]
Parameters
[{"name": "Diagnostic Sensitivity", "reference_range": ">99.9% for coding exons and canonical splice sites"}, {"name": "Analytical Sensitivity", "reference_range": ">99.9%"}, {"name": "Precision (SNVs, indels)", "reference_range": "99.9% detection"}]
Preparation
["No specific fasting required", "Inform lab of any recent blood transfusions or transplants"]
Indications
["Suspected diagnosis of autosomal dominant Robinow syndrome", "Genetic counseling for families with a history of Robinow syndrome", "Prenatal diagnosis in high-risk pregnancies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 52050-5 ICD-10: Q87.8
Clinical summary
This test evaluates the WNT5A gene for pathogenic variants associated with autosomal dominant Robinow syndrome.
TEST-2841
WNT7A Gene Sequencing for Fibular Aplasia/Hypoplasia, Femoral Bowing & Polydactyly (NGS) Test

This test identifies pathogenic variants in the WNT7A gene associated with fibular aplasia/hypoplasia, femoral bowing, and polydactyly.

Peripheral blood (or extracted DNA; FTA card accepted for infants) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the WNT7A gene"]
Parameters
[]
Preparation
[]
Indications
["Neonates or children presenting with fibular hypoplasia/aplasia", "Femoral bowing", "Extra digits", "Family history suggesting autosomal dominant or recessive pattern with limb anomalies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21836-0 ICD-10: Q72.4
Clinical summary
This test identifies pathogenic variants in the WNT7A gene associated with fibular aplasia/hypoplasia, femoral bowing, and polydactyly.
TEST-2190
WRN Gene (Werner Syndrome) Genetic Test

This test evaluates the WRN gene for pathogenic variants associated with Werner syndrome, a rare autosomal recessive disorder characterized by premature aging.

Blood, Extracted DNA, FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["WRN gene sequence", "Pathogenic variants in WRN gene"]
Parameters
[]
Preparation
[]
Indications
["Clinical suspicion of Werner syndrome", "Family history of Werner syndrome", "Carrier screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: E34.8
Clinical summary
This test evaluates the WRN gene for pathogenic variants associated with Werner syndrome, a rare autosomal recessive disorder characterized by premature aging.
TEST-3452
WT-1 Mutation Detection Test

This test detects pathogenic variants in the WT1 gene associated with Wilms tumor and related syndromes.

Blood or bone marrow 18 working days 1,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the WT1 gene"]
Parameters
[]
Preparation
["No fasting required", "Ensure requisition form is fully completed"]
Indications
["Diagnosis of Wilms tumor", "Diagnosis of Denys–Drash syndrome", "Diagnosis of Frasier syndrome", "Risk stratification for Wilms tumor"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92918-3 ICD-10: C64, Z15.07
Clinical summary
This test detects pathogenic variants in the WT1 gene associated with Wilms tumor and related syndromes.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area